Business · 19/11/1998
FDA Releases Draft Guidance for In Vivo Drug Metabolism Studies
The FDA has published a draft guidance for industry outlining recommendations for conducting in vivo drug metabolism and interaction studies for new drugs and biologics, aiming to improve safety and effectiveness assessments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →